Skip to main content
VCbacked
Log inGet Started

Vivere Oncotherapies

Berkeley, United States

Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.

$10.0M raised
Jan 2026
Seed
BiotechnologyTherapeutics

Top Investors

Alumni VenturesPillar VCFreeflow VenturesBerkeley Frontier FundNational Cancer Institute

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vivere Oncotherapies

How much funding has Vivere Oncotherapies raised?
Vivere Oncotherapies has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
Who are Vivere Oncotherapies's investors?
Vivere Oncotherapies's investors include Alumni Ventures, Pillar VC, Freeflow Ventures, Berkeley Frontier Fund, National Cancer Institute.
Where is Vivere Oncotherapies headquartered?
Vivere Oncotherapies is headquartered in Berkeley, United States.
What does Vivere Oncotherapies do?
Vivere develops targeted cancer therapies that activate the immune system to detect and destroy tumors using engineered bio-platforms.
What stage is Vivere Oncotherapies at?
Vivere Oncotherapies is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vivere Oncotherapies — Funding & Investors." VCBacked, January 13, 2026, https://www.vcbacked.co/company/vivere-oncotherapies. Accessed July 2, 2026.
APA
VCBacked. (2026). Vivere Oncotherapies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vivere-oncotherapies
Wikipedia (cite web)
{{cite web |title=Vivere Oncotherapies — Funding & Investors |url=https://www.vcbacked.co/company/vivere-oncotherapies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K